Addendum to: Nature Communications https://doi.org/10.1038/s41467-021-26390-w, published online 22 October 2021
In the original version of the article1, we reported that Lactobacillus-conditioned MRS medium and laboratory-synthesized 1-acetyl-beta-carboline (1-ABC) inhibit a key virulence trait in the human fungal pathogen Candida albicans, namely its ability to undergo yeast-to-hyphal morphogenetic transition. Herraiz et al.2 subsequently discovered that the presence of 1-ABC in Lactobacillus-conditioned medium is not due to bacterial biosynthesis of the compound, but is instead the result of spontaneous chemical reactions that occur in MRS medium under the high pressure and heat that accompany the autoclave sterilization process.
In light of these findings, we conducted follow-up experiments—summarized in our Reply3—that confirmed that 1-ABC is spontaneously generated during the autoclaving of glucose-containing MRS. However, the concentration of 1-ABC in the medium is not sufficient to block morphogenesis of C. albicans without subsequent acidification of the MRS as occurs during the growth of lactobacilli in it. Apparently, our bioassay-guided small-molecule enrichment and isolation process yielded fractions with 1-ABC at concentrations sufficient to block C. albicans morphogenesis, a result that was confirmed with pure, synthetic 1-ABC.
In summary, the generation of 1-ABC during autoclaving in combination with acidification of the culture medium during growth of lactobacilli led us to misinterpret results and erroneously conclude that lactobacilli synthesize 1-ABC. However, all other findings in the original version of the article1, related to the mode of action and therapeutic potential of 1-ABC, remain valid as the experiments were conducted with pure compound.
References
MacAlpine, J. et al. A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase. Nat. Commun. 12, 6151 (2021).
Herraiz, T., Sanchez-Arroyo, A., de las Rivas, B. & Muñoz, R. Lactobacillus species do not produce 1-acetyl-β-carboline. Nat. Commun. https://doi.org/10.1038/s41467-024-50683-5 (2024).
MacAlpine, J. et al. Reply to: Lactobacillus species do not produce 1-acetyl-β-carboline. Nat. Commun. https://doi.org/10.1038/s41467-024-50684-4 (2024).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
MacAlpine, J., Daniel-Ivad, M., Liu, Z. et al. Addendum: A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase. Nat Commun 15, 6440 (2024). https://doi.org/10.1038/s41467-024-50740-z
Published:
Version of record:
DOI: https://doi.org/10.1038/s41467-024-50740-z
